Graeff H - Search Results

1

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer.

Schelling M, Avril N, Nährig J, Kuhn W, Römer W, Sattler D, Werner M, Dose J, Jänicke F, Graeff H, Schwaiger M. Schelling M, et al. Among authors: graeff h. J Clin Oncol. 2000 Apr;18(8):1689-95. doi: 10.1200/JCO.2000.18.8.1689. J Clin Oncol. 2000. PMID: 10764429

2

Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.

Avril N, Dose J, Jänicke F, Bense S, Ziegler S, Laubenbacher C, Römer W, Pache H, Herz M, Allgayer B, Nathrath W, Graeff H, Schwaiger M. Avril N, et al. Among authors: graeff h. J Clin Oncol. 1996 Jun;14(6):1848-57. doi: 10.1200/JCO.1996.14.6.1848. J Clin Oncol. 1996. PMID: 8656253

3

Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Avril N, Dose J, Jänicke F, Ziegler S, Römer W, Weber W, Herz M, Nathrath W, Graeff H, Schwaiger M. Avril N, et al. Among authors: graeff h. J Natl Cancer Inst. 1996 Sep 4;88(17):1204-9. doi: 10.1093/jnci/88.17.1204. J Natl Cancer Inst. 1996. PMID: 8780629

4

Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.

Avril N, Rosé CA, Schelling M, Dose J, Kuhn W, Bense S, Weber W, Ziegler S, Graeff H, Schwaiger M. Avril N, et al. Among authors: graeff h. J Clin Oncol. 2000 Oct 15;18(20):3495-502. doi: 10.1200/JCO.2000.18.20.3495. J Clin Oncol. 2000. PMID: 11032590 Clinical Trial.

5

Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.

Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Jänicke F, Graeff H. Kuhn W, et al. Among authors: graeff h. Gynecol Oncol. 1994 Dec;55(3 Pt 1):401-9. doi: 10.1006/gyno.1994.1313. Gynecol Oncol. 1994. PMID: 7835780

6

[Hydronephrosis as the first manifestation of primary metastatic breast cancer].

Kuhn W, Loos W, Graeff H. Kuhn W, et al. Among authors: graeff h. Geburtshilfe Frauenheilkd. 1994 May;54(5):308-10. doi: 10.1055/s-2007-1022846. Geburtshilfe Frauenheilkd. 1994. PMID: 8050693 Review. German.

7

[Adjuvant therapy of breast cancer: present status and the significance of new prognostic factors].

Jänicke F, Graeff H. Jänicke F, et al. Among authors: graeff h. Rontgenpraxis. 1993 Dec;46(12):371-7. Rontgenpraxis. 1993. PMID: 8303469 Review. German. No abstract available.

8

[-Intravenous or oral etoposide therapy of platinum refractory ovarian cancer with early recurrence. Results of a prospective randomized study-].

Kuhn W, Schmalfeldt B, Dose J, Pache L, Ulm K, Freitag K, Jänicke F, Graeff H. Kuhn W, et al. Among authors: graeff h. Geburtshilfe Frauenheilkd. 1996 Feb;56(2):105-10. doi: 10.1055/s-2007-1022252. Geburtshilfe Frauenheilkd. 1996. PMID: 8647360 Clinical Trial. German.

9

Optimized differential diagnosis of breast lesions by combined B-mode and color Doppler sonography.

Schelling M, Gnirs J, Braun M, Busch R, Maurer S, Kuhn W, Schneider KT, Graeff H. Schelling M, et al. Among authors: graeff h. Ultrasound Obstet Gynecol. 1997 Jul;10(1):48-53. doi: 10.1046/j.1469-0705.1997.10010048.x. Ultrasound Obstet Gynecol. 1997. PMID: 9263423 Free article.

10

Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.

Kuhn W, Schmalfeldt B, Pache L, Späthe K, Ulm K, Renziehausen K, Nöschel H, Canzler E, Richter B, Kroner M, Tilch G, Janicke F, Graeff H. Kuhn W, et al. Among authors: graeff h. Int J Oncol. 1998 Jul;13(1):57-63. Int J Oncol. 1998. PMID: 9625803 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

219 results

Search Page

Filters